Laurie S. Kane-Carson

Synthesis and evaluation of pyrazolo[1,5-b]pyridazines as selective cyclin dependent kinase inhibitors.

D. J. Price, L. Shewchuk, J. Veal, 2008, Bioorganic & medicinal chemistry letters.

Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors.

Alastair J. King, Alex G. Waterson, A. Waterson, 2013, ACS medicinal chemistry letters.

Abstract B88: A selective Raf kinase inhibitor induces cell death and tumor regression of human cancer cell lines encoding B‐RafV600E mutation

A. Waterson, A. King, B. Heidrich, 2009 .

Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases.

J. D. Stuart, A. Truesdale, Laurie S. Kane-Carson, 2007, Bioorganic & medicinal chemistry letters.

Discovery and in vitro evaluation of potent kinase inhibitors: Pyrido[1',2':1,5]pyrazolo[3,4-d]pyrimidines.

K. Lackey, Laurie S. Kane-Carson, E. Wood, 2005, Bioorganic & medicinal chemistry letters.

Dabrafenib; Preclinical Characterization, Increased Efficacy when Combined with Trametinib, while BRAF/MEK Tool Combination Reduced Skin Lesions

A. King, J. Erhardt, D. Uehling, 2013, PloS one.